This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
As u.s. crude storage levels tighten toward a critical threshold, investors face a potentially powerful price signal....
A new Samsung-deepseek partnership is stirring the AI hardware scene. This guide breaks down what DeepSeek could mean...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
Accenture stock has faced a setback as AI and market shifts weigh on the stock. This guide explains the drivers behin...
A fresh $3.4 million investment in Northeast Bank by PMC FIG Opportunities highlights growing interest in regional le...
A quick surge in a mining stock can spark headlines and questions. This guide breaks down the what, why, and how to r...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
The kelpdao hack fallout pushes DeFi developers to accelerate migrations to Chainlink CCIP, with Solv Protocol leadin...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Leveraged ETFs can boost gains in a rising market, but they magnify losses just as quickly. This guide explains how t...
If the CLARITY Act clears Congress, crypto assets could be reclassified into three buckets, altering enforcement, lis...